These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 8410127)

  • 1. Five-year administration of fenretinide: pharmacokinetics and effects on plasma retinol concentrations.
    Formelli F; Clerici M; Campa T; Di Mauro MG; Magni A; Mascotti G; Moglia D; De Palo G; Costa A; Veronesi U
    J Clin Oncol; 1993 Oct; 11(10):2036-42. PubMed ID: 8410127
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of N-4-hydroxyphenyl-retinamide and the effect of its oral administration on plasma retinol concentrations in cancer patients.
    Peng YM; Dalton WS; Alberts DS; Xu MJ; Lim H; Meyskens FL
    Int J Cancer; 1989 Jan; 43(1):22-6. PubMed ID: 2521335
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma retinol level reduction by the synthetic retinoid fenretinide: a one year follow-up study of breast cancer patients.
    Formelli F; Carsana R; Costa A; Buranelli F; Campa T; Dossena G; Magni A; Pizzichetta M
    Cancer Res; 1989 Nov; 49(21):6149-52. PubMed ID: 2529028
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Breast tissue accumulation of retinamides in a randomized short-term study of fenretinide.
    Sabichi AL; Modiano MR; Lee JJ; Peng YM; Xu MJ; Villar H; Dalton WS; Lippman SM
    Clin Cancer Res; 2003 Jul; 9(7):2400-5. PubMed ID: 12855611
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase I trial and pharmacokinetics of fenretinide in children with neuroblastoma.
    Garaventa A; Luksch R; Lo Piccolo MS; Cavadini E; Montaldo PG; Pizzitola MR; Boni L; Ponzoni M; Decensi A; De Bernardi B; Bellani FF; Formelli F
    Clin Cancer Res; 2003 Jun; 9(6):2032-9. PubMed ID: 12796365
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fenretinide breast cancer prevention trial: drug and retinol plasma levels in relation to age and disease outcome.
    Formelli F; Camerini T; Cavadini E; Appierto V; Villani MG; Costa A; De Palo G; Di Mauro MG; Veronesi U
    Cancer Epidemiol Biomarkers Prev; 2003 Jan; 12(1):34-41. PubMed ID: 12540501
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship among pharmacokinetics and pharmacodynamics of fenretinide and plasma retinol reduction in neuroblastoma patients.
    Formelli F; Cavadini E; Luksch R; Garaventa A; Appierto V; Persiani S
    Cancer Chemother Pharmacol; 2010 Oct; 66(5):993-8. PubMed ID: 20532509
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retinoid metabolism in the prostate: effects of administration of the synthetic retinoid N-(4-hydroxyphenyl)retinamide.
    Lewis KC; Hochadel JF
    Cancer Res; 1999 Dec; 59(23):5947-55. PubMed ID: 10606240
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors affecting plasma retinol decline during long-term administration of the synthetic retinoid fenretinide in breast cancer patients.
    Torrisi R; Parodi S; Fontana V; Rondanina G; Formelli F; Costa A; Boccardo F; Decensi A
    Cancer Epidemiol Biomarkers Prev; 1994 Sep; 3(6):507-10. PubMed ID: 8000302
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The hydroxyl functional group of N-(4-hydroxyphenyl)retinamide mediates cellular uptake and cytotoxicity in premalignant and malignant human epithelial cells.
    Hail N; Chen P; Wempe MF
    Free Radic Biol Med; 2010 Dec; 49(12):2001-9. PubMed ID: 20923701
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alteration of retinol-binding-protein concentrations by the synthetic retinoid fenretinide in healthy human subjects.
    Dimitrov NV; Meyer CJ; Perloff M; Ruppenthal MM; Phillipich MJ; Gilliland D; Malone W; Minn FL
    Am J Clin Nutr; 1990 Jun; 51(6):1082-7. PubMed ID: 2140925
    [TBL] [Abstract][Full Text] [Related]  

  • 12. N-(4-hydroxyphenyl)retinamide: interactions with retinoid-binding proteins/receptors.
    Sani BP; Shealy YF; Hill DL
    Carcinogenesis; 1995 Oct; 16(10):2531-4. PubMed ID: 7586162
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of N-(4-hydroxyphenyl)retinamide supplementation on vitamin A metabolism.
    Lewis KC; Zech LA; Phang JM
    Cancer Res; 1994 Aug; 54(15):4112-7. PubMed ID: 8033144
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pilot trial of the safety, tolerability, and retinoid levels of N-(4-hydroxyphenyl) retinamide in combination with tamoxifen in patients at high risk for developing invasive breast cancer.
    Conley B; O'Shaughnessy J; Prindiville S; Lawrence J; Chow C; Jones E; Merino MJ; Kaiser-Kupfer MI; Caruso RC; Podgor M; Goldspiel B; Venzon D; Danforth D; Wu S; Noone M; Goldstein J; Cowan KH; Zujewski J
    J Clin Oncol; 2000 Jan; 18(2):275-83. PubMed ID: 10637240
    [TBL] [Abstract][Full Text] [Related]  

  • 15. N-(4-hydroxyphenyl)retinamide (fenretinide) induces retinol-binding protein secretion from liver and accumulation in the kidneys in rats.
    Schaffer EM; Ritter SJ; Smith JE
    J Nutr; 1993 Sep; 123(9):1497-503. PubMed ID: 8360775
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Secretion of vitamin A and retinol-binding protein into plasma is depressed in rats by N-(4-hydroxyphenyl)retinamide (fenretinide).
    Smith JE; Lawless DC; Green MH; Moon RC
    J Nutr; 1992 Oct; 122(10):1999-2009. PubMed ID: 1388202
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of the fenretinide metabolite 4-oxo-fenretinide present in human plasma and formed in human ovarian carcinoma cells through induction of cytochrome P450 26A1.
    Villani MG; Appierto V; Cavadini E; Valsecchi M; Sonnino S; Curley RW; Formelli F
    Clin Cancer Res; 2004 Sep; 10(18 Pt 1):6265-75. PubMed ID: 15448016
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prospects of chemoprevention of human cancers with the synthetic retinoid fenretinide.
    Costa A; Formelli F; Chiesa F; Decensi A; De Palo G; Veronesi U
    Cancer Res; 1994 Apr; 54(7 Suppl):2032s-2037s. PubMed ID: 8137334
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fenretinide therapy in prostate cancer: effects on tissue and serum retinoid concentration.
    Thaller C; Shalev M; Frolov A; Eichele G; Thompson TC; Williams RH; Dillioglugil O; Kadmon D
    J Clin Oncol; 2000 Nov; 18(22):3804-8. PubMed ID: 11078493
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fenretinide stimulates redox-sensitive ceramide production in breast cancer cells: potential role in drug-induced cytotoxicity.
    Rehman F; Shanmugasundaram P; Schrey MP
    Br J Cancer; 2004 Nov; 91(10):1821-8. PubMed ID: 15505623
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.